Meeting/Workshop

HHS Workshop: Converging on Cancer

The National Toxicology Program within the National Institute of Environmental Health Sciences, Department of Health and Human Services (HHS) will hold a workshop on evaluating the interactions between environmental exposures and cancer biology.

Cancer is a leading cause of mortality worldwide. While the defining feature of cancer is uncontrolled division of abnormal cells, it is a complex disease with varied presentations (i.e., different etiologies and target tissues) that involves dysregulation of multiple interconnected signaling pathways. Diverse environmental factors have been associated with the development and progression of various cancer types. A critical question in the field of environmental health is how to harness what is known about cancer biology and associated environmental exposures to improve public health outcomes. The Converging on Cancer Workshop is aimed at providing a clear path forward for evaluating the interactions between environmental exposures and cancer biology using the latest tools in toxicology and identifying knowledge gaps that require research attention. Potential applications of this understanding include building a framework for incorporating mechanistic data into cancer risk assessment, developing effective screening tools to detect the carcinogenic potential of environmental chemicals (including mixtures), engineering safer products, and designing more effective multi-target therapeutics. 

This meeting is free for members of the public to attend. Attendance will be limited by space available. This workshop will also be webcast. Both in person and online attendance require a registration. The registration links, along with more information regarding the event and a forthcoming agenda, are available at the NTP's website.

HHS Meeting: Presidential Advisory Council on HIV/AIDS

As stipulated by the Federal Advisory Committee Act, the US Department of Health and Human Services is hereby giving notice that the Presidential Advisory Council on HIV/AIDS will be holding a meeting to discuss recommendations regarding programs, policies, and research to promote effective, prevention, treatment and cure of HIV disease and AIDS.

The meeting will be open to the public. Public attendance will be limited by space available, and therefore registration is required for attendance. For more information regarding the meeting, attendance, and a forthcoming agenda, please see this Federal Register notice.

NASEM Symposium: Evidence-Based Interventions to Address the Underrepresentation of Women in Science, Engineering, and Medicine

The National Academies of Sciences, Engineering, and Medicine (NASEM) Committee On Women In Science, Engineering, and Medicine (CWSEM) is organizing a symposium to be centered around evidence-based interventions to address the underrepresentation of women in science, engineering, and medicine.

The scientific, engineering, and medical communities have been working towards improved representation of women in science, technology, engineering, mathematics, and medicine (STEMM) for decades. While progress has been made, women (particularly women of color) remain underrepresented in many scientific, engineering, and medical fields, and at many levels in education and career stages. This symposium will seek to understand institutional barriers to implementing practices for improving the representation of women in STEMM, so that those barriers can be removed or overcome. This event will re-visit the major themes of the 2007 National Academies report, Beyond Bias and Barriers, and will examine policies, practices, and strategies that have demonstrated effectiveness in opening doors to women’s participation and success in STEMM fields. 

This event is free to attend, and requires registration prior to attendance. 

FDA Meeting: Microbiology Devices Panel Advisory Committee

The Food and Drug Administration (FDA) is announcing a forthcoming meeting of the Microbiology Devices Panel Advisory Committee. The committee will discuss and make recommendations regarding new or alternative approaches to the clinical study design and evaluation of devices detecting Human Papillomavirus (HPV) nucleic acid.

These approaches will take into consideration scientific data generated since the approval of the first High Risk (HR) HPV screening device in 2003 as well as the effects of HPV vaccination on clinical studies of devices for HPV detection. Topics to be addressed at the meeting include clinical study design and comparator methods. Additionally, the committee will discuss potential changes to the HR HPV device indications for use considering continually evolving cervical cancer screening guidelines. The committee will provide expert feedback regarding the benefits and risks from the adoption of changes in each of the above topics and make recommendations for future HR HPV device evaluation strategies that are both scientifically rigorous and least burdensome.

Interested persons may present data or information either in written form or orally. Written submissions must be sent by March 1, 2019, while oral presentations will take place during the meeting. For more information regarding the meeting, attendance and public involvement, please see this Federal Register notice

DOE Meeting: Energy Conservation Standards for General Service Lamps

The Department of Energy (DOE) Office of Energy Efficiency & Renewable Energy will hold a public meeting on Appliance and Equipment Standards specifically pertaining to General Service Lamps. General Service Lamps (GSLs) include general service incandescent lamps (GSILs), compact fluorescent lamps (CFLs), general service light-emitting diode (LED) lamps, organic light-emitting diode (OLED) lamps, and any other lamps that are used to satisfy lighting applications traditionally served by GSILs. GSLs are used in general lighting applications and account for the majority of installed lighting in the residential sector.

The meeting is open to members of the public. Those who plan to attend the meeting in person must register via email. In addition, you can attend the public meeting via webinar

More information about the meeting, as well as current standards, notices of rulemaking, and requests for public comment pertaining to General Service Lamps may be found on the DOE webpage.

NIH Workshop: Rare Disease Day

The National Institutes of Health (NIH), National Center for Advancing Translational Sciences (NCATS), announces the 2019 Rare Disease Day at NIH. The event will feature interactive panel discussions on collective research models for rare diseases, patient registries, rare cancer research initiatives, and "no disease left behind, no patient left behind." New this year will be a presentation of the first ever Zebbie award for the NCATS Rare Diseases are Not Rare! Challenge. Other highlights include posters and exhibits by rare disease groups and researchers as well as artwork, videos and NIH Clinical Center tours.

Guest speakers include NCATS Director Christopher P. Austin, M.D.; NIH Clinical Center CEO James K. Gilman, M.D.; and NCATS Office of Rare Diseases Research Director Anne R. Pariser, M.D.

Admission is free and open to the public. In association with Global Genes®, participants are encouraged to wear their favorite pair of jeans.

The day will start with a welcome session, and then move into 4 different panel sessions, each targeted at addressing a sector of rare disease treatment and research. Interested persons should register online. More information regarding the event, including a tentative agenda, can be found at this NIH page

VA Meeting: Rehabilitation Research and Development Service Scientific Merit Review Board, Brain Health and Injury Subcommittee

The Department of Veterans Affairs (VA) gives notice under the Federal Advisory Committee Act that the subcommittee for Brain Health and Injury of the Rehabilitation Research and Development Service Scientific Merit Review Board will meet.

The purpose of the Board is to review rehabilitation research and development applications and advise the Director, Rehabilitation Research and Development Service, and the Chief Research and Development Officer on the scientific and technical merit, the mission relevance, and the protection of human and animal subjects.

The subcommittee meeting will be open to the public for approximately one-half hour at the start of each meeting to cover administrative matters and to discuss the general status of the program.

During the closed portion of each the subcommittee meeting, discussion and recommendations will include qualifications of the personnel conducting the studies (the disclosure of which would constitute a clearly unwarranted invasion of personal privacy), as well as research information (the premature disclosure of which would likely compromise significantly the implementation of proposed agency action regarding such research projects).

Members of the public may attend in person. For more information regarding the meeting and attendance policies, see this Federal Register notice.

CDC Meeting: Advisory Committee on Immunization Practices

The Centers for Disease Control and Prevention (CDC) announces the following meeting of the Advisory Committee on Immunization Practices. The agenda will include discussions on human papillomavirus vaccines, pneumococcal vaccines, Japanese encephalitis vaccines, influenza vaccines, anthrax vaccine, hepatitis vaccines, Pertussis vaccine, herpes zoster vaccine, and meningococcal vaccines. A recommendation vote is scheduled for anthrax vaccine, Japanese encephalitis vaccines, and human papillomavirus vaccines. 

The committee is charged with advising the CDC and Health and Human Services Directors on the use of immunizing agents. In addition, the committee is mandated to establish and periodically review and, as appropriate, revise the list of vaccines for administration to vaccine-eligible children through the Vaccines for Children program, along with schedules regarding dosing interval, dosage, and contraindications to administration of vaccines. 

Members of the public may attend the meeting in person or via webcast. More information is available at the committee's website and at this Federal Register notice.

VA Meeting: Rehabilitation Research and Development Service Scientific Merit Review Board, Spinal Cord Injury/Disorders & Neuropathic Pain Subcommittee

The Department of Veterans Affairs (VA) gives notice under the Federal Advisory Committee Act that the Spinal Cord Injury/Disorders & Neuropathic Pain subcommittee of the Rehabilitation Research and Development Service Scientific Merit Review Board will meet.

The purpose of the Board is to review rehabilitation research and development applications and advise the Director, Rehabilitation Research and Development Service, and the Chief Research and Development Officer on the scientific and technical merit, the mission relevance, and the protection of human and animal subjects. A portion of the meeting open to the public, though no public comments will be taken. 

During the closed portion of the subcommittee meeting, discussion and recommendations will include qualifications of the personnel conducting the studies (the disclosure of which would constitute a clearly unwarranted invasion of personal privacy), as well as research information (the premature disclosure of which would likely compromise significantly the implementation of proposed agency action regarding such research projects). 

Members of the public may attend in person. For more information regarding the meeting and attendance policies, see this Federal Register notice.

VA Meeting: Sensory Systems & Communication Disorders and Chronic Medical Conditions and Aging Subcommittees

The Department of Veterans Affairs (VA) gives notice under the Federal Advisory Committee Act that the Sensory Systems & Communication Disorders and Chronic Medical Conditions and Aging subcommittees of the Rehabilitation Research and Development Service Scientific Merit Review Board will meet.

The purpose of the Board is to review rehabilitation research and development applications and advise the Director, Rehabilitation Research and Development Service, and the Chief Research and Development Officer on the scientific and technical merit, the mission relevance, and the protection of human and animal subjects. A portion of the meeting open to the public, though no public comments will be taken. 

During the closed portion of the subcommittee meeting, discussion and recommendations will include qualifications of the personnel conducting the studies (the disclosure of which would constitute a clearly unwarranted invasion of personal privacy), as well as research information (the premature disclosure of which would likely compromise significantly the implementation of proposed agency action regarding such research projects). 

Members of the public may attend in person. For more information regarding the meeting and attendance policies, see this Federal Register notice.